BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37803899)

  • 21. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
    Shi D; Li L; Zhao Y; Jia Q; Li H; Coulter C; Jin Q; Zhu G
    J Antimicrob Chemother; 2011 Oct; 66(10):2240-7. PubMed ID: 21778195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
    Mekonnen D; Admassu A; Mulu W; Amor A; Benito A; Gelaye W; Biadglegne F; Abera B
    Int J Infect Dis; 2015 Oct; 39():34-8. PubMed ID: 26119857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.
    Seifert M; Catanzaro D; Catanzaro A; Rodwell TC
    PLoS One; 2015; 10(3):e0119628. PubMed ID: 25799046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates].
    Sivkov AIu; Boldyrev AN; Azaev MSh; Bodnev SA; Medvedeva EV; Baranova OI; Ivlev-Dantau AP; Blinova LN; Pasechnikov AD; Tat'kov SI
    Mol Gen Mikrobiol Virusol; 2006; (2):20-5. PubMed ID: 16755998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal.
    Poudel A; Nakajima C; Fukushima Y; Suzuki H; Pandey BD; Maharjan B; Suzuki Y
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2831-6. PubMed ID: 22450970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
    Bolotin S; Alexander DC; Chedore P; Drews SJ; Jamieson F
    J Antimicrob Chemother; 2009 Aug; 64(2):263-6. PubMed ID: 19520719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
    Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
    mBio; 2018 May; 9(3):. PubMed ID: 29844114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
    Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of First-Line Drug Resistance Mutations and Drug-Protein Interaction Dynamics from Tuberculosis Patients in South India.
    Nachappa SA; Neelambike SM; Amruthavalli C; Ramachandra NB
    Microb Drug Resist; 2018 May; 24(4):377-385. PubMed ID: 28813625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
    J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
    Kabir S; Junaid K; Rehman A
    Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Characterization of Mutations in Isoniazid- and Rifampicin-Resistant Mycobacterium tuberculosis Isolated in Thailand.
    Rudeeaneksin J; Phetsuksiri B; Nakajima C; Fukushima Y; Suthachai W; Tipkrua N; Suthum K; Jekloh N; Bunchoo S; Srisungngam S; Klayut W; Hamada S; Suzuki Y
    Jpn J Infect Dis; 2023 Jan; 76(1):39-45. PubMed ID: 36047179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis.
    Hernández-Neuta I; Varela A; Martin A; von Groll A; Jureen P; López B; Imperiale B; Sķenders G; Ritacco V; Hoffner S; Morcillo N; Palomino JC; Del Portillo P
    J Clin Microbiol; 2010 Dec; 48(12):4386-91. PubMed ID: 20881173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates.
    Vijdea R; Stegger M; Sosnovskaja A; Andersen AB; Thomsen VØ; Bang D
    Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1079-86. PubMed ID: 18528720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
    Fenner L; Egger M; Bodmer T; Altpeter E; Zwahlen M; Jaton K; Pfyffer GE; Borrell S; Dubuis O; Bruderer T; Siegrist HH; Furrer H; Calmy A; Fehr J; Stalder JM; Ninet B; Böttger EC; Gagneux S;
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3047-53. PubMed ID: 22470121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.